Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|April 28, 2017
Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trialLennart Tonneijck, Marcel H A Muskiet, Mark M Smits, et al.
Nature Reviews. Nephrology|September 5, 2017
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetesMarcel H A Muskiet, Lennart Tonneijck, Mark M Smits, et al.
Physiological Reports|February 22, 2025
Female glucagon receptor knockout mice are prone to steatosis but resistant to weight gain when fed a MASH-promoting GAN diet and a high-fat dietKatrine D Galsgaard, Emilie Elmelund, Jenna E Hunt, et al.
European Journal of Endocrinology|July 29, 2016
Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trialDaniël H van Raalte, Mathijs C Bunck, Mark M Smits, et al.
Scandinavian Journal of Gastroenterology|April 28, 2017
Smoking is associated with severity of liver fibrosis but not with histological severity in nonalcoholic fatty liver disease. Results from a cross-sectional studyIsabelle D Munsterman, Mark M Smits, Rene Andriessen, et al.
Journal of Diabetes and Its Complications|February 28, 2022
Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivityMichaël J B van Baar, Erik J M van Bommel, Mark M Smits, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|July 2, 2026
The gut microbial lauroyl tryptamine antagonizes oxysterol-GPR183 signaling to modulate lipid-sensitive metabolic pathways in a sex-dependent mannerLiv von Voss, Viktoria M S Kjær, Mark M Smits, et al.
Diabetes, Obesity & Metabolism|July 25, 2016
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patientsMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
The Lancet. Diabetes & Endocrinology|September 20, 2016
Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trialCornelis A J van Beers, J Hans DeVries, Susanne J Kleijer, et al.
Diabetes Care|September 3, 2016
Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled TrialLennart Tonneijck, Mark M Smits, Marcel H A Muskiet, et al.
Pageof 7